SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical
CRIS, Curis (formerly CBMI)
An SI Board Since December 1996
Posts SubjectMarks Bans Symbol
668 42 0 CRIS
Emcee:  Norton Type:  Unmoderated
Introduction Market Data Compact
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
ReplyMessage PreviewFromRecsPosted
568Curis Announces Expansion of Relationship with Centocor Research & Developmebob zagorin-12/15/2005
567Wyeth extends involvement in hedgehog program for neurological disorders. >&tuck-11/21/2005
566The Curious Case of The One-Eyed Sheep Matthew Herper, 11.28.05 How a freakish Icebrg-11/11/2005
565Study sheds light on signaling mechanism in stem cells, cancer UCSF scientists hIcebrg-10/25/2005
564Seems like Curis is trying to get Wyeth to pee or get off the pot, in terms of aExtra Pale-10/25/2005
563Genentech program gets further funding and extension from this December to next tuck-10/13/2005
562Modulation of hair growth with small molecule agonists of the hedgehog signalingIcebrg-9/28/2005
561Curis: Hedgehog Agonists Modulate Hair Growth; Preclinical Data Published In TheJim Oravetz-9/1/2005
560Curis Reiterates 2005 Fincl Outlook, But Sees Higher G&A Expenses DOW JONES Jim Oravetz-8/9/2005
559More of the same. Another 17.900 options exercised and the shares sold. 57.837 oIcebrg-7/21/2005
558Same, same. Passieri has converted another 19.900 options into cash. He seems toIcebrg-7/19/2005
557Passieri exercises another 2.200 options and sells them "all". Net gaiIcebrg-7/18/2005
556Passeri exercised 22.500 options @ 1,50 and immediately sold all the resulting sIcebrg-7/15/2005
55530-Jun-05 Hibernia Southcoast Capital Initiated Buybob zagorin-6/30/2005
554Regulation FD Disclosure. From June 20 through June 22, 2005, representatives oIcebrg-6/24/2005
553Curis to Present at the Bear Stearns Boston Biotech Confab Thursday June 23, 9:0bob zagorin-6/23/2005
552Curis Announces Dosing of First Patient in Phase I Clinical Trial for Basal CellIcebrg-6/22/2005
551Curis Inc Signs Pact For Loan Of Up To $1.45M DOW JONES NEWSWIRES June 15, 2005 Jim Oravetz-6/16/2005
550Curis to Present at the Needham Biotechnology Conference Wednesday May 18, 8:30 bob zagorin-5/18/2005
549Curis to Present at UBS Global Pharmaceuticals Conference Tuesday May 17, 8:30 abob zagorin-5/17/2005
548New Report Suggests Hedgehog Pathway Stimulation Improves Wound Healing in Diabebob zagorin-5/9/2005
547Wonder why the author did not mention the 4 person BCC trial using topical cyclokeokalani'nui-5/6/2005
546Bristling With Promise Startup Curis is developing a class of drugs that could hIcebrg-5/6/2005
545FDA Acceptance Of Application To Initiate Skin Cancer Phase I Clinical Trial DOWJim Oravetz-5/4/2005
544xml.10kwizard.combob zagorin-4/29/2005
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News